Ccr5 Knockout

Constitutive Knockout

Ccr5 Knockout Constitutive Knockout Mouse Model
This model is available for immediate cryorecovery.

C57BL/6 Background

  • Model #
  • Genotype
  • Nomenclature
  • 3737
    B6.129P2-Ccr5tm1Kuz N10
  • Disruption of the Ccr5 gene results in altered immune responses
  • The CC chemokine receptor 5 (CCR5) is the main chemokine receptor for HIV-1 in humans
  • Useful for studies of infectious diseases including HIV-1, malaria, influenza and fungal infections as well as autoimmune disorders

Genetic Background:



The Ccr5 Knockout mouse was developed by William A. Kuziel in the laboratory of Nobuya Maeda at the University of North Carolina. The model was created by targeting the Ccr5 gene in E14TG2a embryonic stem cells derived from 129P2/Ola mice and injecting the targeted cells into C57BL/6 blastocysts. Resultant chimeras were backcrossed to C57BL/6N for ten generations (N10). Taconic received stock in December 2004. The mice were derived by embryo transfer. The colony was maintained by incrossing homozygous mice.





Initial Publication:

Huffnagle GB, McNeil LK, McDonald RA, Murphy JW, Toews GB, Maeda N, Kuziel WA. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol. 1999, 163(9):4642-6.

To purchase this EZcohort model, sign the Terms of Sale (choose from the list below) and email it directly to

This model is sold under terms which grant perpetual use rights.

Welcome! Tell us a little about yourself